Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. - Wikidata - awgldk - TriplyDB

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q33881201

about

Epidemiological studies of esophageal cancer in the era of genome-wide association studies Peroxiredoxin 1 - an antioxidant enzyme in cancer Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.Comparison of the expression of 5 heat shock proteins in benign and malignant salivary gland tumor tissues HMGB1 in health and disease.MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer.Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-An update covering the period 2011-2014.Effects of oxygen on the antigenic landscape of prostate cancer cells.Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis The proteomics big challenge for biomarkers and new drug-targets discovery.A Case-Control Study of Involvement of Oxidative DNA Damage and Alteration of Antioxidant Defense System in Patients with Basal Cell Carcinoma: Modulation by Tumor Removal Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma.Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma.The role of peroxiredoxins in cancer.Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.Novel diagnostic and prognostic biomarkers in esophageal cancer.Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.Serum autoantibodies in the early detection of esophageal cancer: a systematic review.Recent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment.Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer.Proteomics approach to identify biomarkers for upper gastrointestinal cancer.Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.

P2860

Q26852690-F94A5F54-9D1D-4F21-B584-AE8A99176EF8 Q28070359-00A196C0-2D5A-412E-AAEA-E06B93B0E4F9 Q28076178-AAE73E00-8480-4F78-8C8A-BBB183AF7F96 Q28255305-81C4F56D-734D-49F4-AF0F-9FBBFCDD2608 Q28295105-AE40740C-0ED7-4464-949B-EC47B5E3858A Q28550056-3CFC1EE7-E807-48C6-A2CC-33A84ADF1C8F Q33608271-A377682A-1A63-4318-8E3D-1019A4855FAD Q33739952-D90B9B94-1932-4F16-B8D9-970338E6ACE3 Q33895863-21EDAB0B-A381-46C9-9D50-9D0A689BB0F5 Q33895872-996F013E-6548-481B-9C89-D9CA73800398 Q34340255-8D1451D8-D099-468A-87AD-5BCBA5B7C1B0 Q34622835-74634316-DEB1-48DE-89F8-91F02D0CCFE2 Q34820809-1FF922A1-CE36-4B19-904C-AEE5E98F34DE Q34897576-13E5ED4B-3EBC-4694-8A61-958666DAC965 Q35114578-1196DD71-AB0A-4BF9-BCB3-1CBD2E851273 Q35343013-AB0DC083-18B1-4BC0-80ED-E4FAB49D0507 Q35786761-93A60ECA-0D87-46F0-A690-70132506E4D9 Q35799972-2034301A-6AE0-4D6B-B5B9-6518D36D6C25 Q35845496-17A6C182-9317-48A6-98BD-70632333B923 Q35902972-E949F8BB-F00B-4C00-A067-28C91CC54468 Q36264389-67B707F9-96C6-4D77-AF21-723C89CDC752 Q36432402-2477AACD-9F3B-4946-9308-CE9882FC3099 Q36537212-B21081B8-4A1D-4A49-A6CF-EA4BC9C0B0D1 Q37086180-5A0A19EF-7352-4F0D-9630-5CCC8765A645 Q37213540-735CB63A-511B-422A-82BD-B79D1B909811 Q37288443-75E27855-E1C4-4FB1-9EE3-CBD61D45BBAE Q37336576-B7576138-AF6A-4EE2-A359-67240FD741BF Q37701814-11FAAC00-03FA-4196-B953-5D917D9EF416 Q37733163-EEADCD83-B97C-467E-9B6F-D03B839DD7B2 Q38107971-155897E6-B01E-4A16-B19C-7C72E321DFD2 Q38116602-7D88090C-D51F-4F6F-9F51-C2E64F6BBE20 Q38149245-8494005F-7E45-4C1B-9137-BC079A82B379 Q38183143-553229BC-1159-48CB-822E-5AC56EC3B85B Q38272640-32087C8D-49AD-4009-AA11-59D3F805E842 Q38449763-7BB10E6F-AF70-4F79-AB2A-34A616A9B4BD Q38701181-28E515FE-E0A3-46C2-9E44-6EC902778C83 Q38781970-8615AF2D-2FAD-4751-9E09-6056F048C6D3 Q38855553-ED1AC031-A581-4990-B63C-638235ADF5B9 Q38975703-3C34E0CA-B334-480B-BCF4-74FBF85377D5 Q40522259-F13782D4-304F-4180-A03F-AE99CAF96760

P2860

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q33881201

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@ast

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@en

type

label

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@ast

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@en

prefLabel

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@ast

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@en

P1433

Q33881201-5E0A7E4E-238D-49A7-8711-13AF3F013EFB

P1476

Q33881201-26864F04-8F11-46A2-9FF1-A648EDCA5C19

P2093

Q33881201-391DE71C-0062-4E7A-B805-22BF1D03448B

Q33881201-4A04AEF3-D15F-4459-8D14-08F2145EC146

Q33881201-526D7C1E-2B24-4031-B75C-246AB2D42E22

Q33881201-8198CE03-776C-4145-BF19-BC2914BA6BB5

Q33881201-9090AE3F-58C3-4EE8-9640-F1CF5D25A5D1

Q33881201-E07D6001-54B3-42D3-95D9-2C8A5020289A

P2860

Q33881201-011A8595-26F6-4229-80FD-57E748EB633B

Q33881201-0326887A-F11F-4D68-9C07-F67C1412145C

Q33881201-0AC6D1F6-57CF-4A48-9F04-9A6F28BA9CD7

Q33881201-10327136-A824-4EA1-A9A9-6F7BB2B90877

Q33881201-18AF7376-4BD4-4A10-9749-2DC151FF22F6

Q33881201-1B41DD68-612B-4FCD-9B99-C12F7F8C5FAC

Q33881201-1D7177C0-2060-4B1C-AD0A-B79D0351DB07

Q33881201-20C73BD1-FC5A-4AC8-BA5B-AF99AA07B12B

Q33881201-21A71A97-D86C-49DB-B144-409287E5FEF9

Q33881201-2A00E00C-7FCD-4F01-AB3E-3266E5BF0E6C

P304

Q33881201-94F14ABC-3D41-492B-8BC4-963A50C3639F

P31

Q33881201-6F615BD7-90A5-4DFE-8C96-7BC9CF89A1B3

P356

Q33881201-03CA9296-5280-4477-BBE2-E4ED62218B89

P433

Q33881201-62CB433B-B6A7-4CDD-B75A-13B819A66888

P478

Q33881201-D6626139-4D43-449C-BCFB-64CC147946BC

P577

Q33881201-F280D78A-F886-4F88-86B6-F2FC2DBF287D

P5875

Q33881201-6F931BA7-9B61-48FC-B269-41D5192DD023

P698

Q33881201-D723A9AF-5204-4558-9776-F4B82473C28F

P921

Q33881201-11F0AD18-284E-42C6-927D-746CFC9794CE

P932

Q33881201-B02176E3-0143-4781-96ED-F05BD840605F

P356

P1433

Journal of Proteome Research

P1476

Using proteomic approach to id ...... ageal squamous cell carcinoma.

@en

P2093

Jian-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Jianzhong Zhang

http://www.w3.org/2001/XMLSchema#string

Jintao Zhang

http://www.w3.org/2001/XMLSchema#string

Kaijuan Wang

http://www.w3.org/2001/XMLSchema#string

Liping Dai

http://www.w3.org/2001/XMLSchema#string

Samuel S Liu

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

Annexin-1 protects MCF7 breast cancer cells against heat-induced growth arrest and DNA damage

Masquerader: high mobility group box-1 and cancer

Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells

Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma.

Identification of specific protein markers in microdissected hepatocellular carcinoma.

A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells?

Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.

Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.

P304

2863-2872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR200141C

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51074111

http://www.w3.org/2001/XMLSchema#string

P698

21517111

http://www.w3.org/2001/XMLSchema#string

P921

P932

3119842

http://www.w3.org/2001/XMLSchema#string